![Peter Spégel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Spégel
Corporate Officer/Principal chez University of Lund
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Petter Pilesjö | M | - |
University of Lund
| - |
Inge Pettersson | M | 77 |
University of Lund
| 16 ans |
Nils Olof Jarlman | M | 70 |
University of Lund
| - |
Stefan Hansson | M | 59 |
University of Lund
| - |
Merab Kokaia | M | 68 |
University of Lund
| - |
Rajni Hatti-Kaul | M | 65 |
University of Lund
| 20 ans |
Petr Dejmek | M | 79 |
University of Lund
| 35 ans |
Torleif Dahlin | M | 67 |
University of Lund
| - |
Ebba Cecilia Fåhraeus | F | 61 |
University of Lund
| 9 ans |
Stig Steen | M | 76 |
University of Lund
| - |
Ronald W. Pero | M | - |
University of Lund
| - |
Peter Leander | M | 67 |
University of Lund
| - |
Malin Marie Lindstedt | F | 49 |
University of Lund
| - |
Martin Johansson | M | - |
University of Lund
| - |
Per Norlén | M | 54 |
University of Lund
| - |
Andreas Konar | M | 75 |
University of Lund
| - |
Annika Maria Olsson | M | 62 |
University of Lund
| - |
Jacob Engellau | M | 61 |
University of Lund
| - |
Ingegerd Monica Sjöholm | F | 75 |
University of Lund
| - |
Mef Nilbert | F | 57 |
University of Lund
| - |
Anna Kerstin Emy Hultgårdh Nilsson | M | 66 |
University of Lund
| - |
Leif-Göran Salford | M | 83 |
University of Lund
| - |
Carl-Henric Lennart Nilsson | M | 64 |
University of Lund
| - |
Viktor Öwall | M | 69 |
University of Lund
| - |
Susanne Kristensson | F | - |
University of Lund
| - |
Anders Nilsson | M | 56 |
University of Lund
| - |
Mauricio Rojas Mullor | M | - |
University of Lund
| - |
Gabriela Godaly | F | - |
University of Lund
| - |
Malin Malmsjö | M | 51 |
University of Lund
| - |
Jonas Hafström | M | - |
University of Lund
| - |
Björn Kettilsson Wullt | M | 68 |
University of Lund
| - |
Lena Mårtensson | M | 70 |
University of Lund
| - |
Kristina Drott | M | 53 |
University of Lund
| - |
Magnus Fontes | M | 61 |
University of Lund
| - |
Bill Hansson | M | - |
University of Lund
| - |
Christer Thordson | M | 66 |
University of Lund
| - |
Karin Leandersson | F | 52 |
University of Lund
| - |
Anders Sigvard Bjartell | M | 65 |
University of Lund
| - |
Roland Andersson | M | 69 |
University of Lund
| 24 ans |
Catharina Svanborg | M | 75 |
University of Lund
| 35 ans |
Sofia Ulver | M | 53 |
University of Lund
| - |
Lars Christer Oxelheim | M | 80 |
University of Lund
| - |
Jan Nilsson | M | 71 |
University of Lund
| - |
Helena Norrman | F | 54 |
University of Lund
| - |
Bengt Arvid Westrin | M | 66 |
University of Lund
| 25 ans |
Magnus Ingelsten | M | - |
University of Lund
| - |
Jan-Erik Solem | M | - |
University of Lund
| - |
Artur Schmidtchen | M | - |
University of Lund
| - |
Jörgen Hegbrant | M | 67 |
University of Lund
| - |
Stina Margareta Gestrelius | M | 75 |
University of Lund
| - |
Fredrik Höök | M | - |
University of Lund
| 20 ans |
Margareta Linden | M | - |
University of Lund
| 31 ans |
Sven Fredrik Tiberg | M | 61 |
University of Lund
| - |
Lars-Erik Magnus Wernersson | M | 56 |
University of Lund
| 19 ans |
Jan Erik Ragnar Söderberg | M | 68 |
University of Lund
| - |
Boel Flodgren | M | 82 |
University of Lund
| - |
Tomas Leanderson | M | 68 |
University of Lund
| 34 ans |
Ingrid Anne-Marie Pålsson | M | 73 |
University of Lund
| - |
Jan Thorell | M | - |
University of Lund
| - |
Klas Rune Arildsson | M | 64 |
University of Lund
| - |
Lars Gösta Montelius | M | 66 |
University of Lund
| - |
Ulla Cristina Glad | M | 72 |
University of Lund
| - |
Tadeusz Wojciech Wieloch | M | 74 |
University of Lund
| - |
Henrik Tobias Thorlacius | M | 55 |
University of Lund
| - |
C. Mike Lu | M | 54 |
University of Lund
| - |
Olov Arvid Sterner | M | 71 |
University of Lund
| - |
Signhild Lou E Arnegård-Hansen | F | 64 |
University of Lund
| - |
Jonas Erjefält | M | 58 |
University of Lund
| - |
Boris Zhmud | M | - |
University of Lund
| - |
Jeanette Jakobsson | F | 57 |
University of Lund
| - |
Per Belfrage | M | 84 |
University of Lund
| - |
Inga Sarah Maria Fredriksson | M | 56 |
University of Lund
| - |
Peter Jelkeby | M | 61 |
University of Lund
| - |
Thoas Michael Fioretos | M | 66 |
University of Lund
| - |
Guido Zacchi | M | 74 |
University of Lund
| 35 ans |
Lars Magnus Thomas Bjursten | M | 75 |
University of Lund
| 35 ans |
Tommy Evert Andersson | M | 68 |
University of Lund
| 28 ans |
Hakon Leffler | M | - |
University of Lund
| - |
Carl Johan Kördel | M | 62 |
University of Lund
| 30 ans |
Mona Annelie Sylvén-Troedsson | F | 75 |
University of Lund
| - |
Sune Roland Svanberg | M | 81 |
University of Lund
| - |
Gustaf Olsson | M | 84 |
University of Lund
| 18 ans |
Bo Mattiasson | M | - |
University of Lund
| 52 ans |
Jing Liu | M | 53 |
University of Lund
| - |
Javier Linares-Pastén | M | 60 |
University of Lund
| - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Peter Viberg | M | 48 |
Nanosep AB
![]() Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | 8 ans |
Gustaf Sverker Littorin | M | 69 |
Nanosep AB
![]() Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | - |
Snickar Karl Johan Tobieson | M | 50 |
Nanosep AB
![]() Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | - |
Leif Schweitz | M | 55 |
Nanosep AB
![]() Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | - |
Staffan Nilsson | M | 74 |
Nanosep AB
![]() Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | - |
Per Åke Oldentoft | M | 82 |
Nanosep AB
![]() Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | - |
Patrik Söderlund | M | - |
Nanosep AB
![]() Nanosep AB Miscellaneous Commercial ServicesCommercial Services Nanosep is a company with a new high performing environmentally friendly analytical technology to be used in the pharmaceutical and biotech industry. With the Nanosep technology, a customer can easily get results from complicated samples such as blood plasma and pharmaceutical products. Both faster, with less effort and with higher precision compared to technologies available on the market. Transmission electron microscopy image of a prototype to Nanosep RP. One unique feature in the separation process is that the equipment is self regenerated continuously, which enables a user to perform all separations on a new fresh column. The technology is consequently designed to be able to handle complicated and contaminating samples, such as blood plasma and advanced drug formulations. The unique technology is based on Nanoseps patented polymer nanoparticles, the Nanosep RP. The business concept of Nanosep AB is to commercialize Nanosep RP and to develop a family of products. Nanosep RP will be sold in small vials that the user directly can use with his existing equipment. With Nanosep RP, the performance and stability of the system will be greatly improved, which will give user satisfaction through reliable information and rich data on projects. | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Suède | 92 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Peter Spégel
- Réseau Personnel